Structural and ICAM-1-Docking Properties of a Cyclic Peptide from the I-domain of LFA-1: An inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion

• Published in: Journal of biomolecular structure & dynamics 2002-04, Vol.19 (5), p.789-799
• Main Authors: Xu, Christine R., Yusuf-Makagiansar, Helena, Hu, Yongbo, Jois, Seetharama D.S., Siahaan, Teruna J.
• Format: Article
• Language: English
• Subjects: Cations; Cell Adhesion; Circular Dichroism; Humans; Intercellular Adhesion Molecule-1 - chemistry; Intercellular Adhesion Molecule-1 - metabolism; Lymphocyte Function-Associated Antigen-1 - chemistry; Lymphocyte Function-Associated Antigen-1 - metabolism; Magnetic Resonance Spectroscopy; Models, Molecular; Peptides - chemistry; Protein Binding; Protein Conformation; Protein Structure, Tertiary; T-Lymphocytes - cytology
• ISSN: 0739-1102; 1538-0254
• DOI: 10.1080/07391102.2002.10506785

The purpose of this work was to study the conformation of cyclic peptide 1, cyclo(1,12)- Pen1-Ile2-Thr3-Asp4-Gly5-Glu6-Ala7-Thr8-Asp9-Ser10-Gly11-Cys12-OH, derived from the I-domain of the LFA-1 α-subunit. We found that cyclic peptide 1 can bind to the D1- domain of ICAM-1 and inhibit ICAM-1/LFA-1-mediated homotypic and heterotypic T-cell adhesion. To understand the bioactive conformation and binding requirements for cyclic peptide 1, its solution structure was studied using NMR, CD, and molecular dynamics simulations. Furthermore, possible binding properties between the cyclic peptide and the D1- domain of ICAM-1 were evaluated using docking experiments. This cyclic peptide has a stable βII'-turn at Asp4-Gly5-Glu6-Ala7 and a βI-turn at Pen1-Ile2-Thr3-Asp4; a less stable βV-turn is found at the C-terminal region. The β-turn at Asp4-Gly5-Glu6-Ala7 was also found in the X-ray structure of the I-domain of LFA-1. Our CD studies showed that the peptide binds to calcium/magnesium and forms a 1:1 (peptide:calcium/magnesium) complex with low cation concentrations and multiple types of complexes with higher cation concentrations. Binding to divalent cations causes a conformational change in peptide 1; this is consistent with our previous study that binding of peptide 1 to ICAM-1 was influenced by divalent cations. Docking studies show the interaction between cyclic peptide 1 and the D1- domain of ICAM-1; it indicates that the Ile2-Thr3-Asp4-Gly4-Glu6-Ala7-Thr8 sequence interacts with the F and C strands of the D1-domain. Finally, these studies will help us design a new generation of selective peptides that may bind better to the D1-domain of ICAM-1.